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Abstract 
Cardiac cell therapy holds a real promise for improving heart function and especially of the 
chronically failing myocardium. Embedding cells into 3D biodegradable scaffolds may better 
preserve cell survival and enhance cell engraftment after transplantation, consequently 
improving cardiac cell therapy compared with direct intramyocardial injection of isolated cells. 
The primary objective of a scaffold used in tissue engineering is the recreation of the natural 
3D environment most suitable for an adequate tissue growth. An important aspect of this 
commitment is to mimic the fibrillar structure of the extracellular matrix, which provides 
essential guidance for cell organization, survival, and function. Recent advances in 
nanotechnology have significantly improved our capacities to mimic the extracellular matrix.  
Among them, electrospinning is well known for being easy to process and cost effective. 
Consequently, it is becoming increasingly popular for biomedical applications and it is most 
definitely the cutting edge technique to make scaffolds that mimic the extracellular matrix for 
industrial applications. 
Here, the desirable physico-chemical properties of the electrospun scaffolds for cardiac 
therapy are described, and polymers are categorized to natural and synthetic. Moreover, the 
methods used for improving functionalities by providing cells with the necessary chemical cues 
and a more in vivo- like environment are reported. 
 
Keywords: electrospinning, tissue engineering, cardiac cells, heart therapy, biopolymers, 
functional scaffold, surface modification 
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1. Introduction  
Cardiovascular diseases are the leading cause of disability, limiting the activity and eroding the 
quality of life of millions of both middle age adults and elderly each year. The Global Burden of 
Disease study estimated that 29.6% of all deaths worldwide (15.6 million deaths) were caused 
by CVDs in 2010 [1]. Among them, more than 7 million are due to ischemic cardiomyopathies 
which lead mainly to acute myocardial infarction and chronic heart failure [2]. Both the 
incidence and prevalence of the latter condition are steadily increasing, primarily because 
early revascularization of myocardial infarctions in industrialized countries results in a higher 
rate of survival and thus leaves an increasing number of patients at risk of developing a 
subsequent left ventricular dysfunction. 
Although heart transplantation remains the only radical treatment for end̻stage heart failure, 
its indications are limited by organ shortage and the complications associated with major 
immunosuppression. Mechanical assist devices are still primarily used as bridges to transplant 
(or recovery) and despite its ability to provide symptomatic relief, biventricular 
resynchronization fails in 20% to 30% of patients [3]. Finally, none of the large trials 
implemented over the last decade to investigate new drugs has yielded a positive outcome 
leading to an increased survival of heart failure patients, except for the recent paradigm trial 
which has reported the benefits of the angiotensin receptor-neprilysin inhibitor LCZ696 [4]. Put 
together, these observations have provided a rationale for exploring new therapeutic options, 
among which “regeneration” of the chronically failing heart by stem cells has raised a 
tremendous interest. 
Stem cell therapy aims at restoring some functionality in these scarred regions by providing a 
new pool of functional contractile elements [8] [9] [10]. However, although multiple cell types 
have been tested experimentally, only skeletal myoblasts and bone marrow̻derived cells have 
been assessed in large clinical trials, while cardiac “stem cells”, cardiospheres, and 
adipose̻derived stroma cells are still under current investigation [5]. Benefits have been found 
marginal and most likely due to the paracrine effects of the transplanted cells rather than to a 
true “regeneration” of the scarred myocardium originating from the graft. A thorough analysis 
of the reasons for this failure has led to identifying poor cell engraftment as a major 
contributor to suboptimal outcomes. A major reason for these suboptimal results is likely the 
low rate of engraftment and high mortality of the transplanted cells into diseased hearts. 
These two phenomena are caused by a mechanical leakage of cells [6][7][8] and subsequently 
worsened by an interplay of biologic factors that include inflammation, ischemia due to poor 
vascularization of the injected areas, and apoptosis subsequent to detachment of anchorage̻ 
dependent cells from their extracellular matrix (ECM), so-called anoikis [9]. The recognition of 
these contributing factors provides a rationale for embedding cells into 3D biodegradable 
scaffolds using tissue engineering that may better preserve cell survival and enhance cell 
engraftment after transplantation, consequently improving cardiac cell therapy compared with 
direct intramyocardial injection of isolated cells. 
Tissue engineering for cellular based transplantation has the following advantages: 
1. It can provide a 3D environment to the cells which is more reminiscent of the endogenous 
cardiac tissue. This patterning is critical for cell survival because it avoids the proteolytic 
dissociation which is required prior to injection; 
2. It allows delivering multiple cell populations: the stem cells under consideration and the 
“support” cells aimed at providing them with the trophic support required for their survival, 
differentiation, and migration; 
3. It can serve as a platform for growth factors delivery that should positively impact on the 
grafted cells as well as on the target myocardial environment. 
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Various tissue̻engineered scaffolds have been studied as a cardiac patch for myocardial repair 
and shown to prevent heart failure by increasing the mechanical strength of the infarct, 
thereby inhibiting adverse left ventricular remodeling and deterioration of cardiac function 
[10]. In order to build these 3D constructs, ECM components such as collagen and fibrin can be 
used to make elastic gels with compositions similar to the body’s ECM. Gels in an 
unpolymerized form can be mixed with cells, and the resulting polymerized matrix creates 
specific geometric shapes. In Zimmermann et al.’s study, collagen and cardiomyocytes (CMs) 
were combined into circular molds, which displayed interconnected, beating cells when 
implanted in infarcted rat hearts [11]. 
Alternatively, gels and transplantable cells can also polymerize in vivo after injection, 
permitting the cell̻matrix composite to assemble and conform to specific areas of the 
myocardium. Two separate studies in rats have used skeletal myoblasts in injectable fibrin 
matrices and embryonic stem cell in collagen matrices, respectively. Both studies reported 
small decreases in heart failure progression [12][13]. Despite all these different gel setups, 
some problems remain. The relatively low concentration of CMs limits the force of contraction 
and once again, adequate vascularization is a challenge unless cells endowed with an 
angiogenic potential are added to gel mixtures to foster new vessel formation [14]. 
Another approach has consisted of developing scaffold̻free cell sheets obtained by culturing 
cells onto temperature̻sensitive dishes so that, upon cooling, a cell sheet can be collected and 
overlaid on the diseased area [15][16]. The Okano’s group, which has pioneered this approach, 
has reported quite successful outcomes with different cell types (skeletal myoblasts, 
mesenchymal stem cells (MSCs), cardiac progenitors) [17]. The major advantage of this 
approach is to avoid any foreign material and the subsequent inflammatory response these 
materials may trigger. However, these cell sheets also raise practical issues associated with 
their frailty, the difficulty in safety manipulating them for transfer onto the target region and 
their propensity to fold and tear. These drawbacks have likely limited their clinical acceptance 
and fully justify the alternate use of scaffolds that feature better handling characteristics. 
As the primary objective of a scaffold used to build a tissue engineered patch is to recreate the 
natural 3D environment most suitable for an adequate cell and tissue growth, an important 
aspect of this commitment is to mimic the fibrillar structure of the ECM, which provides 
essential guidance for cell organization, survival, and function. Recent advances in 
nanotechnology have significantly improved our capacities to mimic the ECM via synthetic 
techniques originally developed in the fields of microfabrication for microelectronics, 
microfluidics [18][19] and of membrane separation technologies [20]. Several technologies 
have been investigated for the fabrication of polymeric scaffolds that mimic this geometry, 
including; solvent casting/particulate leaching, gas foaming, freeze drying, thermally induced 
phase separation, photolithography, electrospinning, rapid prototyping techniques such as 3D 
printing, laser ablation [21][22][23], except from the decellularization of tissues [24]. Each 
technique presents advantages and limitations, which have been reported in various review 
articles [25][26][27]. 
Among them, electrospinning is the only one that can be used for industrial applications as it 
can be effectively up-scaled. This is demonstrated by the continuous growth of electrospinning 
equipment in the market the last years [28]. Briefly, in the traditional electrospinning, a 
polymeric solution is fed through a thin needle opposite to a grounded collector and a high 
voltage is applied to form a jet of the solution that travels from the needle to the collector, 
where is deposited in the form of dried nanofibers. Many variations have been developed in 
the last decade for upscaling the process such as needle-free set-ups. The parameters that can 
be adjusted for the nanofibers formation include the solution properties (viscosity, 
conductivity, surface tension, molecular weight, concentration and architecture of the 
polymer), the process parameters (electric potential, flow rate, needle to collector distance, 
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collector shape and composition) and ambient parameters (temperature, humidity). This 
technique is well known for being easy to process and cost̻effective. Consequently, it is 
becoming increasingly popular for biomedical applications, and it is most definitely the 
cutting̻edge technique to make patches that mimic the ECM for industrial applications [28]. 
Concerning the material of use for electrospinning, a plethora of polymers have been tested, 
and most of them use organic solvents. Electrospun nanofiber matrices show morphological 
similarities to the natural ECM characterized by continuous fibers ranging from nano to micro 
scale, high surface-to-volume ratio, high porosity and variable pore-size distribution. Efforts 
have also been made to modify nanofiber surfaces with several bioactive molecules to provide 
cells with the necessary chemical cues and a more in vivo-like environment. In addition, 
physico-chemical properties of nanofiber matrices can be controlled by manipulating 
electrospinning parameters to meet the requirements of a particular application [29]. 
All the above parameters render electrospinning as a very good candidate for the fabrication 
of scaffolds for cardiac tissue engineering which ideal properties are described in the next 
section. In the same line, another gain of electrospinning is the variety of nanofibrous 
structures that can be constructed beyond the morphology of the fiber. The advances in 
electrospinning set-up and mainly on the type of collector allows for the development of 
various constructs. For example, modules of electrospinning such as high-speed rotating drum 
and mandrel collectors can allow for the formation of aligned nanofibers. In addition, 
collectors designed with a specific structure on demand to the desirable application can work 
as a master for the formation of a nanofibrous construct of choice, e.g. valves, vessels. For 
example, electrospun nanofibers of natural biopolymer could be made as a monolayer on a 
honeycomb microframe and transformed by crosslinking into a mesh with controllable pore 
sizes, which can more closely mimic the ECMs [30][31]. Of course, there are techniques that 
are based on computer-aided design (CAD) on which a structure of choice can be fabricated, 
such as photolithography and 3D printing. Nevertheless, the main advantage of 
electrospinning is still the low-cost and the simplicity, renders it as a method that can be 
adapted even in a biological laboratory as neither specialized engineers nor infrastructure are 
required (e.g. clean-room facilities in the case of photolithography). It should be stated that all 
the aforementioned benefits of electrospinning do not apply exclusively to cardiac but also to 
other areas of tissue engineering. In the light of cardiac tissue engineering on which except 
from the structural characteristics, electro-mechanical properties (conductivity, elasticity) are 
of paramount importance, the versatility of electrospinning is an asset since conductive 
polymers and other additives can be co-electrospun in order to achieve the desired properties.  
In the current review an up to date overview of the electrospun scaffolds used so far for 
cardiac tissue engineering purposes is presented. In the vast majority, cardiac cells were 
seeded in the scaffolds and their proliferation was evaluated. Amongst them, the primacy 
belongs to CMs, as in most of the cases the final target is the treatment of the failing 
myocardium. Nevertheless, interesting studies, although much less, have been presented for 
the treatment of other parts of the heart such as the replacement of valves and vessels. The 
various materials and methods for improving electrospun scaffolds functionalities for cardiac 
tissue engineering are reviewed. 
 
2. Polymeric scaffold characteristics for cardiac tissue engineering 
Once the principle of using a scaffold has been adopted, some key parameters need to be 
determined. These are material composition, surface characteristics, mechanical properties, 
biocompatibility, degradation rate and cell seeding conditions. The conductivity of the scaffold 
also appears to play an important role on scaffolds used for cardiac tissue engineering. 
Production cost and manufacturing conditions compatible with regulatory guidelines for 
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human applications are additional factors that need to be taken into consideration. A 
comprehensive description of the requirements for a functional cardiac scaffold can be found 
in review articles such as [27][32][33], whereas herein a synopsis is presented. 
Myocardial tissue shows a hierarchical structure with aligned fibrous cells embedded into 3D 
honeycomb-like micro-patterns formed by both undulated perimysial collagen fibers and 
different proteins of the ECM [34][35]. Thus, a scaffold with fibrous structure is crucial for cell 
organization, survival, and function of the seeded cardiac cells. To respect anisotropic 
organization of cardiac tissue and promote development of a functional cardiac syncytium, the 
fibrous structure needs to be aligned. Several studies demonstrated that the presence of 
aligned surface facilitates the orientation and organization of CMs [36][37]. Moreover, high 
surface-to-volume ratio and porosity are indispensable elements for the migration of cells and 
vascularization.  
Regarding to the mechanical properties, it should be taken into consideration that the best 
scaffold for cardiac tissue regeneration should have a Young´s modulus between tens of kPa 
and 1MPa, since it has been reported that left ventricular stiffness is about 10-20 kPa at the 
beginning of diastole and in the range 0.2-0.5 MPa at the end of diastole [38]. Other studies 
indicated that the Young’s modulus of the native heart tissue is in the range of 10–15 kPa [39] 
while in the case of ischemic tissue, associated with fibrosis, it increases up to 30-50 kPa [40]. 
Furthermore, Engler et al. using isolating cardiac cells demonstrated that CMs were only able 
to form mature sarcomeres with regular beating on polyacrylamide gels of about 10 kPa [39]. 
On softer gels, sarcomeres were less spaced and not fully organized whereas on stiffer gels, 
myocytes contained more stress fibers and did not display sarcomeres.  
In addition, attention has been driven towards conductivity, another key characteristic of 
scaffolds for cardiac tissue engineering, given that cardiac cells beat using electric signals 
which transport through the myocardium. Electrical stimulus is known to control surface 
properties by controlling surface charge [41]. The same principle is applied to control the 
attachment, proliferation, and differentiation of cells [42]. Kai et al. measured an increase in 
connexin 43 (gap junction protein marker involved in electrical signal transmission expression), 
which is the primary cardiac connexin, in conductive scaffolds comparing to other non-
conductive ones [43]. The application of electrical stimulus showed to be in favour of the 
creation of cardiac tissue in several studies. Tandon et al. showed that by inducing electric 
stimulation, they promoted the formation of long and well-aligned sarcomeres as well as 
intercalated discs between aligned Z line, similarly to that of healthy cardiac tissue [44]. 
Spontaneous and synchronous beating of cardiac cell when cultured on conductive scaffolds 
was reported by Dvir et al. [45]. In other studies, the expression of several cardiac-related 
markers, i.e. Nkx2.5, GATA4, cardiac troponin t, troponin I, connexin 43, desmin, slow myosin 
and fast myosin were expressed while culturing stem cells (human MSCs and rat bone marrow 
MSCs) on conductive scaffolds and subjected to electrical stimulation [46][47]. 
Two other important issues to be taken into consideration are biocompatibility and 
biodegradability, which allow support of both the appropriate cellular activity and the 
generation of new tissues. In some cases, bioresorbability is required. Generali et al., described 
thoroughly the requirements of bioresorbable scaffolds for cardiovascular tissue engineering, 
and their mechanisms of degradation once they have been implanted [48]. The biomaterials to 
be used for the elaboration of the scaffolds for heart tissue regeneration need to be 
compatible with the natural tissue and the cells with a low inflammatory response after 
implantation. The biomaterials also need to support cell adhesion, differentiation, and 
proliferation. Natural polymers such as collagen, fibrin and polysaccharides have shown their 
potential for leading to efficient cell differentiation and enhanced interaction with cardiac 
cells. However, most of the natural polymers suffer from poor mechanical properties. 
Synthetic biocompatible/biodegradable polymers such as polyesters are a solution when 
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higher mechanical properties are required. The next section is dedicated to the detailed 
presentation of the most common electrospun scaffolds made of natural and synthetic 
polymers, which are used in cardiac tissue engineering. 
The last important issue is related to cell seeding conditions. A diverse range of cell seeding 
techniques has developed over the past decades to promote cell seeding efficiency and 
consequently long-term graft function. The most common method used in tissue engineering 
is static seeding, in which a concentrated cell suspension is passively introduced on a scaffold. 
This technique has several limitations that result in low seeding efficiency and minimal cell 
penetration into the scaffold. To overcome these limitations, alternate seeding techniques 
have been developed, including dynamic, magnetic, vacuum, electrostatic, and centrifugal 
seeding. Each technique presents different advantages, but the final selection of the 
appropriate method should be made in accordance with the polymer and the scaffold 
fabrication techniques. Advances in the area of microfabrication and microfluidics lead to the 
development of different types of bioreactors such as rotating and perfusion-based [49] 
[50][51].  
From all the above, it is evident that the ideal scaffold for cardiac tissue engineering would be 
the one that combines the following characteristics. (a) Appropriate mechanical properties 
that match the mechanical properties of the native cardiac tissue (anisotropy, elasticity, 
contractility etc.) (b) Appropriate structure that mimics the microenvironement of the native 
cardiac tissue (fibrous anisotropic alignment characteristic of the myocardium, porosity, 
nanomorphology etc.) (c) Appropriate surface (bio)chemistry to promote cardiac cell 
attachment, proliferation, viability, similar to this of the native cardiac tissue (biocompatibility, 
wettability, etc.) (d) Appropriate conductivity of the scaffold to allow propagation of electrical 
stimulation which as discussed above has been proven to have a positive effect on cell 
behaviour. In the next sections of this study, the methods and approaches used to try to 
achieve these desired functionalities are presented and discussed.  
 
3. Polymeric materials: natural and synthetic 
The various requirements for functional cardiac tissue scaffolds have resulted in the 
development of a plethora of different fabrication approaches and materials utilization. 
Electrospinning is ranked as the most popular method of fabricating nanofiber scaffolds via 
synthetic engineering, and it has already shown a number of advantages for tissue engineering 
purposes [52][53][54][55].  A statistical graph of the articles published over the last 12 years 
using electrospun scaffolds for cardiac tissue engineering applications is depicted in figure 1. 
The first article in the area was published in 2004. From then on, there is an evident increasing 
interest in this type of bioscaffolds. 
Generally speaking, the electrospun nanofibers can be manufactured at low cost from 
different types of polymers. They can be engineered to have different mechanical and 
biochemical properties. The biopolymers used are usually categorized into natural and 
synthetic [56][57]. Both categories have advantages and drawbacks. Natural polymers have 
intrinsically the necessary biochemical cues for cells attachment and proliferation. Their 
degradation products are non-toxic and have a low immune response. However, most of this 
category of polymers requires an extra crosslinking step to become insoluble in aqueous-based 
solutions such as culture media. The crosslinking may affect not only their 3D structure and 
porosity, but also their biocompatibility due to the introduction of non-biocompatible chemical 
agents [58]. In addition, the selection of the correct solvent system is crucial in order to avoid 
or reduce denaturation. Synthetic polymers have high reproducibility and have a simple quality 
control process. Moreover, their cost is much lower in comparison to the natural ones and 
their mechanical properties can be tuned more effectively. But they are missing of biochemical 
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cues which should be introduced either via adding an extra step of functionalization or via 
combining them with natural polymers. 
 
   
Figure 1. Articles published over the last 12 years proposing electrospun scaffolds for cardiac tissue 
engineering. 
 
3.1 Natural polymers 
The common natural polymers used in cardiac tissue engineering include collagen, fibrinogen, 
chitosan, gelatin, elastin and silk. 
Collagen is the predominant material out of the natural polymers, its term comes from the 
Greek words “κόλλα” and “γεννώ” that literally means “glue producer” and constitutes the 
main component of the ECM. Matthews et al demonstrated that collagen may be used to 
produce a nearly ideal scaffold for tissue engineering [59], whereas Yow et al showed that 
collagen can also be electrospun with other types of polymers, allowing efficient proliferation 
of human MSCs and maintenance of their multipotency for up to 7 days [60].  
The main collagens of interest to cardiovascular engineering are the collagen types I and III. 
Collagen is an essential component of myocardial connective stroma, which is mainly 
composed of type I and III fibrillar collagen, and its arrangement may contribute to preserve 
heart microarchitecture and chamber geometry [61]. Several reports have emphasized that 
the architecture of myocardial collagen fibers, in particular of the endomysium, may be 
involved in the regulation of the mechanical activity of the heart [62]. In addition, collagen has 
a long-standing safety record for medical applications, which should streamline translational 
processes towards clinics [58]. 
Clinically approved collagen electrospun scaffolds have been used as supports for H9c2 
cardiomyoblasts culture. Among different types of collagen samples, it was found that 
atelocollagen can produce electrospun fibers of better quality than acid and basic fibrous 
collagen. Immunostaining for actin and nuclei demonstrated the colonization of the scaffold 
under optimized crosslinking conditions, where the cardiomyoblasts were spread all over the 
scaffold and showed a nice structure of their actin filaments [63]. 
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Figure 2. Improvement of cardiac function in a non-ischemic dilated mouse model following epicardial 
implantation of the cellularized collagen scaffold. A) SEM image of the fibrous scaffold; B) 
Biocompatibility test; C) Cellularisation, immunolabeling against α-actinin of hiPS-CM seeded onto a 
collagen scaffold for 3 days.; D) Presence of new vessels after grafting. Scale bars  for A) 2 µm; B) 100 
µm; C) 20 µm ; D) 30 µm. Reprinted with permission from [64]. 
 
This type of collagen electrospun scaffolds has been recently used for the delivery of human 
induced pluripotent stem cell-derived CMs (hiPS-CM) in a mouse model of dilated 
cardiomyopathy (DCM) (figure 2). Acellular collagen scaffolds were first implanted in both 
healthy mice and in those where DCM was induced by a cardiac-specific invalidation of serum 
response factor (SRF). Seven and fourteen days after implantation, the safety of the scaffold 
was demonstrated by echocardiography and histological assessments. The subsequent step of 
implantation of the scaffolds seeded with hiPS-CM in DCM induced mice, using cell-free 
scaffolds as controls, revealed that after fourteen days, heart function had decreased in 
controls while it remained stable in the treated mice. This pattern was associated with an 
increased number of endothelial cells, in line with the greater vascularity of the scaffold. 
Moreover, a lesser degree of fibrosis consistent with the upregulation of several genes 
involved in ECM remodeling was observed. These results support the interest of the proposed 
hiPS-CM seeded electrospun scaffold for the stabilization of the DCM outcome with potential 
for its clinical use in the future [64]. 
Fibrinogen is a glycoprotein, synthesized by the liver and found freely circulating in the 
bloodstream which plays a major role in clotting. Fibrinogen has proved to induce improved 
cellular interactions and scaffold remodeling compared to synthetic scaffolds. It has the ability 
to bind with high affinity to functional vascular endothelial growth factor (VEGF), fibroblast 
growth factor (FGF), and a number of other cytokines [65]. Even if the ability to create 
fibrinogen nanofibers by electrospinning has been demonstrated, more studies are required 
for their in vitro cellular interactions behaviour. As a first study, McManus et al. cultured 
neonatal rat cardiac fibroblasts onto fibrinogen electrospun scaffolds. Those cultures were 
treated to regulate scaffold degradation by either supplementing serum-containing media with 
aprotinin or crosslinking the scaffolds with glutaraldehyde vapor. Cell culture demonstrated 
that fibroblasts readily migrate into and remodel electrospun fibrinogen scaffolds with 
deposition of native collagen [66]. 
Another natural polymer that exhibits desirable characteristics for tissue engineering is chitin, 
along with its deacetylated derivative, chitosan. Chitin is the second most abundant 
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polysaccharide after cellulose, and has a similar structure [67]. Chitosan, apart from its 
biocompatibility, biodegradability, non-toxicity, has low cost. Electrospun chitosan was utilized 
to provide structural scaffolding characterized by scale and architectural resemblance to the 
ECM in vivo. Hussain et al. studied ventricular CMs from neonatal rats in various culture 
conditions (i.e., mono- and co-cultures) for their viability and function by using electrospun 
chitosan-based nanofiber scaffolds [68]. The results demonstrated that the chitosan 
nanofibers retained their cylindrical morphology in long-term cell cultures and exhibited good 
cellular attachment and spreading in the presence of the adhesion molecule fibronectin. CM 
mono-cultures resulted in a loss of CM polarity and islands of non-coherent contractions. 
However, the CM-fibroblast co-cultures resulted in polarized CM morphology and retained 
their morphology and function for long-term culture. The Cx43 expression in the fibroblast co-
culture was higher than in the CM mono-culture and endothelial cell co-culture. In addition, 
fibroblast co-cultures demonstrated synchronized contractions involving large tissue-like 
cellular networks. This first attempt to test chitosan nanofiber scaffolds as a 3D cardiac co-
culture model demonstrated that chitosan nanofibers can serve as a potential scaffold that can 
retain cardiac structure and function. 
Elastin is composed of covalently cross-linked molecules of its precursor, tropoelastin, a 
soluble, non-glycosylated and highly hydrophobic protein. Tropoelastin expression and 
subsequent elastin synthesis typically occurs in fibroblasts, vascular SMCs, endothelial cells, 
and chondrocytes [69]. However, very limited studies have been published for electrospun 
scaffolds containing only elastin for cardiac tissue engineering purposes [58] [70]. In most of 
the cases elastin constitutes one part of an electrospun composite as it will be described 
subsequently. 
Silk is composed of a glue-like sericin protein which role is to hold fibers together, and a fibroin 
filament component which acts as the mechanical backbone. Natural silk fibers have tensile 
strength and yield at fracture values comparable to synthetic polymeric fibers, and can be 
slowly absorbed in vivo as biocompatible amino acids. In tissue engineering applications, 
typically silk fibroin is utilized. A blend of silk fibroin and poly (ethylene oxide) (PEO) was used 
for the fabrication of electrospun fibers, where both human aortic endothelial cells (hAEC) and 
human coronary artery smooth muscle cells (hCASMC) were seeded [71]. Both hAECs and 
hCASMCs demonstrated an affinity for the electrospun silk fibroin/PEO. hCASMCs were shown 
to elongate and align themselves with SF fibers as well as produce native collagen ECM. 
Balasubramanian et al. fabricated bio-composite scaffolds by using fibrinogen and gelatin in 
two different weight ratios and performing cross-linking [Fib/Gel (1:4)-CL; Fib/Gel(2:3)-CL], 
while cross-linked fibrinogen scaffolds were used as the control sample [72]. The tensile 
strength and the stiffness values of Fib/Gel(1:4)-CL matrices were found to be 0.0125 and 0.46 
MPa respectively, which were much similar to the innate properties of the native myocardium. 
Cell culture studies using human CMs revealed higher cell proliferation on Fib/Gel(1:4)-CL 
scaffolds compared to Fib/Gel(2:3)-CL scaffolds, which was even higher than the cell 
proliferation on cross-linked fibrinogen scaffolds. Moreover, the CMs seeded on composite 
substrates expressed typical functional cardiac proteins such as α-actinin, troponin I, connexin-
43, and myosin heavy chain, thereby raising the possibility of applications in cardiac tissue 
engineering. 
 
Table I. Electrospun scaffolds based on natural polymers in cardiac tissue engineering. 
Material 
Fibers 
morphology 
Cultured cells In vitro In vivo 
Publication 
year 
Ref. 
fibrinogen random 
rat neonatal cardiac 
fibroblasts 
   2007 [66] 
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silk fibroin/PEO random 
human aortic 
endothelial cells (hAEC) 
& human coronary 
artery smooth muscle 
cells (hCASMC) 
   2008 [71] 
chitosan random 
ventricular CMs from 
neonatal rats, & 
coculture with 
fibroblasts 
   2013 [68] 
fibrinogen/gelatin random CMs    2013 [72] 
albumin 
random & 
aligned 
rat neonatal CMS    2014 [73] 
collagen random H9c2    2015 [63] 
collagen random CMs, hiPSCs   
 mouse 
model of 
DCM 
2016 [64] 
 
Moreover, a 3D cardiac patch fabricated from albumin fibers has been recently reported [73].  
The fabricated aligned and randomly oriented electrospun albumin fibers had improved 
elasticity and were capable of adsorbing serum proteins, such as laminin, leading to strong 
cell-matrix interactions. Additionally, due to the functional groups on their backbone, the 
fibers could be chemically modified with essential biomolecules. Scaffolds culture with rat 
neonatal CMs induced the assembly of aligned cardiac tissues with high aspect ratio (length-to-
diameter ratio) CMs and massive actinin striation, which was more significant in the case of 
the aligned scaffolds. Compared to synthetic PCL fibrous scaffolds, CMs cultured within aligned 
or randomly oriented scaffolds formed functional tissues, exhibiting significantly improved 
function that generated strong contraction forces. 
Table I summarizes the scaffolds characteristics, in terms of material used, fibers morphology 
and in vitro/in vivo studies for the case of using natural polymers for electrospinning for 
cardiac tissue engineering. From the above, it is concluded the significance of adjusting the 
elasticity of the scaffolds. Regarding to the fibers alignment, only in the case of albumin both 
aligned and random fibers were tested where the first ones led to improved functional tissues. 
It is evident that more studies in the future should be performed using aligned structures 
which better mimic the native cardiac tissue anisotropy as it has been reported in the section 
2. The materials with better performance so far proved to be collagen, chitosan, albumin and 
silk with the latter possessing superior mechanical properties, especially for vascular grafts. 
The importance of co-culture CMs with fibroblasts is another aspect that should be taken into 
account for better mimicking of the natural ECM microenvironment and is an indication that 
research should focus towards this direction. 
 
3.2 Synthetic polymers 
There is a plethora of synthetic polymers used for the fabrication of electrospun scaffolds, 
containing not only one polymer but in the vast majority combinations of different ones 
and/or combinations with natural polymers for the enhancement of their properties. Their 
main advantage is their electrospinnability and cost effectiveness, but on the other hand 
treatment/modification of their surface is usually needed for cell culture purposes. 
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3.2.1 Poly(ε-caprolactone)-based scaffolds 
The results of the literature research have clearly revealed that the synthetic material of 
choice for the majority of scientists is poly(ε-caprolactone) (PCL). Shin et al. have shown that 
PCL fiber meshes of 250 nm average fiber diameter suspended on a wire ring support 
attachment and contraction of neonatal rat CMs in vitro [74]. On day 3, CMs start to contract 
weakly and in an unsynchronized fashion. These contractions become stronger and 
synchronized as time progresses. CMs adhered, populated the entire scaffold mesh, and 
stained positively for cardio-specific proteins [75]. This highly porous non-woven PCL mesh 
functions as a temporary ECM that enables the cells to adhere, spread, proliferate and 
establish electrical communications between layers creating synchronized beating. This mesh 
did not restrict the contractile functions of the CMs and the wire ring provides passive tension 
that supports maturation of the beating CMs, and may improve handling of the construct 
[76][77]. 
Howbeit, the high stiffness and hydrophobicity of the PCL fiber mesh does not provide 
significant cell attachment and proliferation in cardiac tissue engineering. Many studies have 
been carried out towards the improvement of PCL characteristics, for example Venugopal et al. 
proposed a blend of PCL and collagen types I and III [78]. The tensile modulus of the structures 
was 18 MPa with a tensile strength of 7.79 MPa, appropriate for a blood vessel conduit. 
Furthermore, the proliferation of coronary artery smooth muscle cells (CASMCs) seeded on 
PCL/collagen scaffolds has significantly increased. 
The combination of PCL with different natural polymers such as collagen, elastin and gelatin 
has revealed that electrospun PCL/gelatin scaffolds showed a higher tensile strength when 
compared to the other hybrid scaffolds according to Heydarkhan-Hagvall et al. [79]. The effects 
of pore size on cell attachment and migration was determined by in vitro studies using 
adipose-derived stem cells culture, where cell migration into the scaffold was predominantly 
seen in the PCL/gelatin hybrid.  
In another study, random and aligned PCL/gelatin composite nanofibrous scaffolds were 
electrospun to structurally mimic the oriented ECM [80]. Results indicated that PCL/gelatin 
nanofibrous scaffolds possessed smaller fiber diameters (239 ± 37 nm for random fibers and 
269 ± 33 nm for aligned fibers), increased hydrophilicity, and lower stiffness compared to 
electrospun PCL nanofibers. The aligned PCL/gelatin nanofibers showed anisotropic wetting 
characteristics and mechanical properties, which closely match the requirements of native 
cardiac anisotropy. Rabbit CMs were cultured on electrospun random and aligned nanofibers 
to assess the biocompatibility of scaffolds, together with its potential for cell guidance. It was 
revealed that the aligned PCL/gelatin scaffold greatly promoted cell attachment and alignment 
because of the biological components and ordered topography of the scaffolds.  
Reddy et al. proposed a compound of PCL and an oligomer hydrogel [Bisphenol A ethoxylated 
dimethacrylate (BPAEDMA)] for the fabrication of electrospun scaffolds [81]. The elastic 
modulus of PCL/BPAEDMA nanofibrous scaffolds was found to be decreased with the increase 
of the BPAEDMA weight fraction. Compound scaffolds containing 75 wt % BPAEDMA oligomer 
hydrogel exhibited lower modulus (3.55 MPa) and a very low contact angle (25
o
). BPAEDMA 
with high degree of ethoxylation resulted to highly flexible elastomeric hydrogels when treated 
by UV radiation. The contained soft ethylene oxide segments of the blended oligomer provided 
flexibility and allowed bioadhesion of cells, while the polymerizable methacrylate end groups 
supplied mechanical strength tunability. In addition, these elements are both non-toxic and 
non-immunogenic, which are two essential requirements for biocompatible implantable 
materials. Photopolymerization of this oligomer led to the formation of flexible elastomeric 
hydrogel films and nanofibers [82]. Rabbit  CMs cultured for 10 days on these PCL/ BPAEDMA 
scaffolds, remained viable and expressed cardiac troponin and alpha-actinin proteins for the 
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normal functioning of myocardium, where cell adhesion and proliferation were significantly 
increased on scaffolds containing 75 wt % BPAEDMA. 
Chen et al. managed to seed murine iPSCs (miPSCs) directly on a 3D PCL nanofibrous scaffold – 
which was previously coated with a layer of gelatin - and initiated non-directed, spontaneous 
differentiation using the monolayer method [83]. At day 15 of differentiation, miPSCs 
differentiated into functional CMs on the 3D PCL nanofibrous scaffold, as evidenced by positive 
immunostaining of cardiac-specific proteins including cardiac troponin T (cTnT) and myosin 
light chain 2a (MLC2a). In addition, flow cytometric analysis of cTnT-positive cells and cardiac-
specific gene and protein expression of cTnT and sarcomeric α-actinin,  demonstrated that the 
CM differentiation of miPSCs was more efficient on the 3D PCL nanofibrous scaffold than on 
normal tissue culture plates .  
Furthermore, Fleischer et al. fabricated a 3D spring-like fiber scaffold of PCL for cardiac tissue 
engineering, in view that coiled fibers have a key role within the natural fibrous matrix of the 
myocardium, allowing the synchronous contraction and relaxation of cardiac cell bundles with 
minimal energy loss [84]. The hypothesis was that since in vivo straightening and re-coiling of 
these fibers allows stretching and contraction of the myocardium in the direction of the CMs, 
such a scaffold can support the assembly of a functional cardiac tissue capable of generating a 
strong contraction force (figure 3.1). Rat CMs engineered within 3D thick spring-like fiber 
scaffolds formed a functional tissue exhibiting significantly improved function, including 
stronger contraction force, higher beating rate, and lower excitation threshold, compared to 
straight fiber scaffolds. These scaffolds, composed of tortuous fibers, had an average pore area 
of 44000 mm2, corresponding to a pore diameter of 470 mm which allowed the penetration of 
cells and their assembly into bundles of myocytes. 
 
 
Figure 3. (1). Schematic representation of a CM contraction and relaxation on an ECM fiber: A) Spring-
like fibers support cell stretching by providing physical support without resistance, while B) straight 
fibers resist CM stretching. (C) SEM image of scaffolds prepared from coiled fibers. Scale bar: 50 mm 
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Reprinted with permission from [84]. (2) Schematic diagram explaining the fabrication process of a 
model fibrosa layer. Reprinted with permission from [85]. 
 
Guex et al. demonstrated that radio-frequency plasma surface functionalized electrospun PCL 
fibres provide a suitable matrix for bone-marrow-derived MSCs cardiac implantation. The 
plasma treatment method characteristics will be reported in the section 4.2.2. The designed 
cardiac patch, acellular vs. seeded with MSCs, was evaluated in a rodent model of chronic 
myocardial infarction (MI) and it was revealed that MSC-seeded plasma-coated PCL grafts 
stabilized cardiac function and attenuated dilatation. Significant relative decreases of 13% of 
the ejection fraction (EF) and 15% of the fractional shortening (FS) were observed in sham 
treated animals; respective decreases of 20% and 25% were measured 4 weeks after acellular 
patch implantation, whereas a steady function was observed 4 weeks after MSC-patch 
implantation (relative decreases of 6% for both EF and FS) [85]. 
An interesting application of electrospinning was presented by Jana et al. who fabricated an in 
vitro model of the fibrosa layer of a cardiac aortic valve using PCL [86]. Fibrosa layer is 
composed mostly of a dense network of type I collagen fibers oriented in circumferential 
direction. Thus, a morphologically biomimicking and standalone substrate with 
circumferentially oriented nanofibers was fabricated by electrospinning on an appropriately 
designed collector (figure 3.2). Cultured valvular interstitial cells (VICs) from porcine aortic 
valve showed a fibroblast phenotype that is generally observed in a healthy aortic leaflet, and 
their morphology was close to those in the fibrosa layer of a native aortic leaflet, rendering this 
approach promising for in vitro studies of valvular dysfunctions. 
 
3.2.2 Scaffolds based on PLLA, PLGA and their copolymers 
Another category of materials used for cardiac tissue purposes are the polymers poly-(L-
lactide) (PLLA), polyglycolide (PGA) and the copolymer poly(lactide-co-glycolide) (PLGA). 
In vitro studies of biodegradable non-woven PLGA-based scaffolds using primary CMs from 
rats have shown a dose–response effect of the PGA concentration on the degradation rate and 
the pH value changes [87]. It was found that CMs had a preference for relatively hydrophobic 
surfaces such as PLLA. PLLA scaffolds promoted better cell adhesion and mature cytoskeleton 
structure with well-defined periodic units in the contractile machinery (sarcomeres). 
Functional studies of CMs on the scaffolds, by optical imaging of electrical activity using 
voltage-sensitive dyes, substantiated the superior response on PLLA scaffolds compared to 
PLGA + PLLA and PLGA + PEG–PLA (poly(ethylene glycol)–poly(D,L-lactide) diblock copolymer). 
Co-electrospinning of PLGA with two natural proteins - gelatin and a-elastin - led to stable 
scaffolds in an aqueous environment without crosslinking, which were more elastic than those 
made of pure elastin fibers [88]. The PLGA–gelatin–elastin scaffold turned into stable fiber-
laden hydrogel in an aqueous medium, with suitable mechanical properties which were 
adjusted by the ratio of the components. Cytocompatibility tests with H9c2 rat cardiac 
myoblasts revealed that myoblasts grew equally as well or slightly better on the scaffolds than 
on tissue-culture plastic. Myoblasts reached confluence on the scaffold surfaces while 
simultaneously growing into the scaffolds. 
A 3D culture system based on electrospun PGA was fabricated for the study of cell lines of 
cardiac stem cells (CSCs) using a c-kit antibody from adult rat hearts which has previously being 
established by the same group [89]. C-kit -positive cardiac cells are well recognized as CSCs and 
have the potential to differentiate into CMs [90] although some studies have rather suggested 
a preferential differentiation towards the vascular cell lineage [91]. Composites of collagen-
PGA were prepared, that contained different amounts of electrospun PGA nanofibers, where 
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the latter were added as a sheet that formed a layer within the collagen sponge. The sponges 
were freeze-dried and then dehydrothermally crosslinked. The PGA nanofibers significantly 
enhanced the compressive strength of the collagen sponge. The attachment and proliferation 
of CSCs in the 3D culture was enhanced by incubation in a bioreactor perfusion system 
compared with 3D static and 2D (i.e. tissue culture plates) culture systems. 
In vitro studies of hiPSCs using aligned PLGA electrospun nanofibers coated on cell culture 
plates have shown that these cells better approximate normal cardiac tissue compared with 
those cultured on a flat surface, indicating the desire of an anisotropic environment [92]. In 
addition, electrospun PLGA-collagen (PLGA-Col) scaffolds have been studied as substrates for 
the differentiation of pluripotent embryonic stem cells (ESCs) isolated from the inner mass of 
blastocysts. During the culture of embryoid bodies’ outgrowth on the scaffolds, and further 
differentiation of ESCs to CMs, the PLGA-Col nanofibers were found superior than electrospun 
PLGA nanofibers, as a better interaction and growth of ESC differentiated CMs was observed 
on the composite scaffolds. PLGA scaffolds were found hydrophobic with a contact angle of 
128.11
0
, whereas PLGA/Col scaffolds showed hydrophilic properties with a contact angle of 
48.89
0
. The hydrophilic PLGA/Col nanofibers might serve as a favourable scaffold compared to 
PLGA for cardiac treatment [93]. 
Moreover, a scaffold consisting of a commercial copolymer of LLA with trimethylene carbonate 
(PLLA-co-TMC) was investigated in comparison to electrospun PLLA. The PLLA-co-TMC scaffold 
is a glassy rigid material at room temperature while it is a rubbery soft material at 37
0
C. 
Mechanical characterization results (tensile stress–strain and creep-recovery measurements) 
showed that at 370C electrospun PLLA-co-TMC displayed an elastic modulus of around 20 MPa 
and the ability to completely recover up to 10% of deformation. Cell culture experiments have 
shown that this copolymer scaffold promotes CMs proliferation and preserves cell 
morphology, without impeding expression of sarcomeric α-actinin marker [94]. 
Another combination of PCL and PGA of various compositions showed that with the increase of 
the concentration of PGA in spinning blend solution, the average diameter of nanofibers, 
hydrophilicity, and mechanical properties of the nanofibrous scaffolds increased. An in vitro 
degradation study of PCL:PGA nanofibers conducted in phosphate buffered saline confirmed 
that increasing the amount of PGA provides faster degradation rate in blended nanofibers. Cell 
attachment and spreading of cardiac progenitor cells (isolated from newborn rat heart) seeded 
on the scaffolds indicated that among electrospun nanofibrous scaffolds, the most appropriate 
candidate for myocardial tissue engineering scaffolds is PCL:PGA (65:35) [95].  
A composite of electrospun poly(1,8-octanediol-co-citrate) (POC) and PLLA-co-PCL (PLCL) was 
proposed by Prabhakaran et al., where its mechanical properties can be adjusted by tuning the 
amount of POC [96].The composite scaffold with POC/PLCL ratio of 40:60 [POC/PLCL4060] was 
found to have a tensile strength of 1.04 ± 0.11 MPa and Young’s modulus of 0.51 ± 0.10 MPa, 
comparable to the native cardiac tissue. The proliferation of cardiac rat myoblast cells (H9c2) 
on the electrospun POC/PLCL scaffolds increased from days 2 to 8, with the increasing 
concentration of POC in the composite. The morphology and cytoskeletal observation of the 
cells also demonstrated the biocompatibility of the POC containing scaffolds, indicating that 
electrospun POC/PLCL4060 nanofibers can be promising elastomeric substrates. 
An electrospun composite of PLA with poly(ethylene glycol) dimethacrylate (PEGdma) was 
developed aiming to mimic the structure and mechanical properties of native valve leaflets 
[97]. As PLA is highly hydrophobic, PEGdma, which can be photochemically crosslinked, was 
used to additionally stabilize the fibrous scaffold. Culture of VICs and valvular endothelial cells 
(VECs) on the scaffold under physiological conditions in a bioreactor resulted in a construct 
with performance like a native leaflet. Atomic force microscopy (AFM) revealed that spongiosa 
stiffness was much lower compared to the fibrosa and ventricularis. Taking into consideration 
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investigations into human fetal heart valve development that identified collagen type I and 
versican as key structural proteins, they were introduced to the scaffold in order to 
demonstrate the ability of this hybrid valve biofunctionalization. 
Recently, heterogenous nanofibrous scaffolds consisted of PLCL and the hydrophilic poly(ethyl 
oxazoline) (PEOz) at specific ratio have been demonstrated to mimic the native collagen fiber 
heterogeneity of the left ventricular cardiac tissue [98]. These scaffolds contain fibers with two 
different diameters of 100 - 150 nm and ∼500nm, obtained by electrospinning the 
aforementioned blend. H9c2 cells culture has shown improved cell compatibility along with 
the expression of cardiac marker proteins in the case of PLCL/PEOz at ratio 70:30. 
 
3.2.3 Polyurethane-based scaffolds 
Polyurethane (PU) based electrospun materials are another category often used for the 
construction of heart valves. For example, primary cardiac ventricular cells were grown on 
electrospun, biodegradable PU with either aligned or unaligned microfibers and supported 
high-density cultures and cell subpopulations, remained intact over two weeks in culture [99]. 
PU cultures contained electrically-coupled CMs with connexin-43 localized to points of cell-cell 
contact. Multi-cellular organization correlated with microfiber orientation and aligned 
materials yielded highly oriented CM groupings. Atrial natriuretic peptide (ANP), a molecular 
marker that shows decreasing expression during ventricular cell maturation, was significantly 
lower in cultures grown on PU scaffolds than in those grown on tissue culture polystyrene. 
Cells grown on aligned PU had significantly lower steady state levels of ANP and constitutively 
released less ANP over time indicating that scaffold-imposed cell organization resulted in a 
shift in cell phenotype to a more mature state, suggesting that the physical organization of 
microfibers in PU scaffolds impacts both multi-cellular architecture and cardiac cell phenotype 
in vitro. PU mesh scaffolds were utilized for the generation and seeding of ESC-derived CMs as 
well. The cells were elongated in shape, morphology typical of cultured ESC-derived CMs, 
sarcomeric myosin and connexin 43 expression was evident, and contracting cells were 
observed [100]. In addition, the same research group studied the effect of scaffold 
architecture and co-culture with mouse embryonic fibroblasts (MEFs) on the differentiated 
phenotype of murine ESC-derived CMs (mESCDCs) [101]. Both aligned and random fibrous PU 
scaffolds were fabricated by electrospinning, and it was found that the aligned scaffolds led to 
the anisotropic organization of rodshaped cells, improved sarcomere organization, and 
increased mESCDC aspect ratio when compared to cells on the random-fibrous scaffolds. 
Moreover, pre-seeding the scaffolds with MEFs improved mESCDC sarcomere formation 
compared to mESCDCs cultured alone. 
Biodegradable thermoplastic elastomers are attractive for application in cardiovascular tissue 
construct development due to their amenability to a wide range of physical property tuning. 
For example, electrospun poly (ester urethane) ureas (PEUU) were developed by Stankus et al. 
which demonstrated the integration of living cells into electrospun PEUU scaffolds [102]. 
Vascular SMCs isolated from rat aorta were electrosprayed simultaneously with the 
electrospinning of PEUU using a rotating mandrel collector, resulting in SMC microintegrated 
PEUU constructs with high cells density achieved in a short period of time and with high 
anisotropy. A comprehensive study of the same group of electrospun PEUU under variable 
conditions which modelled the effects of fiber orientation on the macro-mechanical properties 
of the scaffold, has shown that the high velocity electrospun scaffolds exhibited highly 
anisotropic mechanical properties closely resembling the native pulmonary heart valve leaflet 
[103].  Aiming to mimic the mechanical properties of a native pulmonary valve in both flexural 
and equi-biaxial tensile response, Amaroso et al. studied the effect of microstructural features, 
that are important on the flexural behaviour of electrospun scaffolds, by introducing 
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secondary electrospun fibers to the PEUU with simultaneous electrospinning [104]. It was 
noticed that mixed fiber constructs with higher modulus had higher bending and tensile 
moduli when secondary fibers were stiffer (PCL) than PEUU, whereas sacrificial fibers (PEO) 
within scaffolds were found to decrease overall construct modulus. Hobson et al. presented 
another approach of developing curvilinear fiber alignment in electrospun scaffolds by varying 
the geometry of the collecting mandrel in order to mimic the native semi-lunar heart valves 
[105]. PEUU was electrospun onto rotating conical mandrels of varying angles to produce 
fibrous scaffolds where the angle of fiber alignment varied linearly over scaffold length. By 
matching the radius of the conical mandrel to the radius of curvature for the native pulmonary 
valve, the electrospun constructs exhibited a curvilinear fiber structure similar to the native 
leaflet (figure 4).  
 
 
Figure 4. A. Picture of the conical mandrel during production of curvilinear electrospun sheets. B. 
Scheme of the flattened, conical electrospun sheet (top) and image of the excised leaflet with SEM 
images. Reprinted with permission from [105]. 
 
Moreover, using knitted conventional textiles made of cotton or polyester yarns as templates 
of electrospinning collectors, Senel Ayaz et al. created anisotropic 3D scaffolds from 
polycarbonate-urethane (PCU, Bionate®), which exhibited mechanical properties close to 
native in comparison to PLGA ones [106]. In vitro studies (initially with H9c2 cells) with 
neonatal rat CMs demonstrated the functionality in terms of physiologic contractility of the 
electrospun anisotropic polyester-templated Bionate scaffolds. 
A composite based on PU and ethyl cellulose (PU/EC) was fabricated featuring uniform fibrous 
nanostructures and 3D porous networks which proved to be biocompatible for retention and 
proliferation of cardiac myoblast H9c2 cells [107]. The high mechanical strength of the PU/EC 
scaffolds enables the processing and handling of an ultrathin patch. Their elastomeric 
characteristics revealed the compatibility between the patch and contractile tissues. 
Furthermore, anisotropic PU/EC scaffolds with aligned nanofibers were successfully fabricated, 
exhibiting higher mechanical strength and essential characteristics for the survival and 
function of cardiac cells with native anisotropy.  
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3.2.4 Poly(glycerol sebacate)-based scaffolds 
Poly(glycerol sebacate) (PGS) has emerged in the last decade, as a very attractive polymer for 
soft tissue engineering [108]. Indeed, PGS is a thermoset elastomer synthesized from nontoxic 
monomers, glycerol and sebacic acid, which can be degraded and completely resorbed in vivo. 
A PGS/gelatin core-shell electrospun composite reported for the co-culture of MSCs and CMs 
[109]. In this composite PGS used as a core polymer to impart the mechanical properties and 
gelatin as a shell material to achieve favorable cell adhesion and proliferation. The cardiogenic 
differentiation of MSCs was confirmed by employing MSC-specific marker protein CD 105 and 
cardiac-specific marker protein actinin. Ravichandran et al. supported that the co-culture of 
MSCs and CMs with a suitable elastomeric biomaterial combination such as PGS/gelatin has 
synergistic effects and are more effective than MSCs or CMs alone.  
Whereas, in another study, PGS and gelatin were blended before electrospinning resulting to 
the fabrication of scaffolds with well-defined anisotropy that can mimic the left ventricular 
myocardium architecture [110]. From the in vitro studies using neonatal rat cardiac fibroblast 
cells (CFs) and CMs, it was found that aligned fibrous scaffold, consisting of 33 wt. % PGS, 
induced optimal synchronous contractions of CMs while significantly enhanced cellular 
alignment.  
Kenar et al. used a polyester blend consisted of PGS, poly(3-hydroxybutyrate-co-3-
hydroxyvalerate) (PHBV) and P(L-D,L)LA and for the fabrication of aligned electrospun mats 
[111]. The basic 3D construct design involved two biodegradable macroporous tubes, to allow 
transport of growth media to the cells within the construct, and cell-seeded, aligned fiber mats 
wrapped around them. The electrospun parallel fibers proved to be effective for the alignment 
of MSCs from human umbilical cord matrix (Wharton’s Jelly) after their culture on them, where 
the cells were able to retract the mat. The 3D construct was cultured in a microbioreactor by 
perfusing the growth media transiently through the macroporous tubing for two weeks and 
enhanced cell viability, uniform cell distribution and alignment due to nutrient provision from 
inside the 3D structure were confirmed. 
Non-linearly elastic biomaterials were successfully fabricated from a chemically cross-linked 
elastomeric PGS and PLLA using the core/shell electrospinning technique [112]. The 
electrospun materials, containing a PGS core and PLLA shell, demonstrated J-shaped stress–
strain curves and displayed ultimate tensile strength, rupture elongation, and stiffness 
constants comparable to muscle tissue properties. In vitro evaluations also showed that 
PGS/PLLA fibrous biomaterials possess excellent biocompatibility, capable of supporting 
human ESC-derived CMs over several weeks in culture. 
An electrospun fibrous blend of PGS and poly(butylene succinate-butylene dilinoleate) (PBS-
DLA) of different compositions was examined for its suitability for heart patches [113]. The 
addition of PBS-DLA to PGS resulted in an increase of the average fiber diameter, whereas 
increasing the amount of PBS-DLA the elastic modulus was increased as well as the 
hydrophobicity of the blended scaffolds. Initial toxicity studies with C2C12 myoblast cells up to 
72h confirmed the nontoxic behaviour of the blends.  CMs culture results contradicted those 
of the C2C12 cells, where the PBS-DLA 70/30 scaffolds showed the lowest cell viability. Authors 
claimed that CMs seem to be more sensitive to the matrix stiffness, showing better 
attachment and maturation on the softer matrix. Comparing to the controls used in the study 
(gelatin- and fibronectin-coated glass coverslips), CMs attach and spread much faster on 
PGS/PBS-DLA fiber blends than on gelatin and the same as fibronectin. 
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3.2.5 Scaffolds based on other polymeric materials 
Recently Castellano et al. presented an extensive study on the ability for cardiac repair of 
various electrospun scaffolds including poly(3-hydroxybutyrate) (PHB), PCL, silk, PLLA, 
polyamide (PA) which were compared to a non-crosslinked collagen membrane that was used 
as control [114]. In vitro studies using mouse cardiac HL-1 cell line, cardiac fibroblasts and 
MSCs from dental pulp showed that PHB and PCL polymers allowed the greatest 
adhesion/growth of cells. In vivo studies with acellular patches on the epicardial surface of 
healthy rats have shown that only collagen and PHB patches were progressively degraded. 
Implantation on infarcted rat heart indicated that only PHB induced significant angiogenesis. 
Nevertheless, in vivo studies with cell-seeded patches are required in order to prove the 
superior properties of PHB electrospun scaffolds. 
Scaffolds made of lipase-catalyzed poly(ω-pentadecalactone) (PPDL) have been reported by 
Focarete et al. [115]. The main advantage of PPDL is its slow resorbability which is essential in 
tissue-engineering applications that require long healing times. The biocompatibility of PPDL 
scaffolds was evaluated using embryonic rat cardiac H9c2 cells. It was demonstrated that H9c2 
cells retain their native, mesenchymal spindle shaped, sheet-like morphology and cover the 
scaffold surface with a confluent cell monolayer, which is promising for the usage of PPDL 
scaffolds for cardiac tissue engineering. 
Polydioxanone (PDO) electrospun bioabsorbable valved patches were studied for restoring the 
right ventricular outflow tract (RVOT) [116]. The scaffold seeded with MSCs was implanted in 
the right ventricular outflow tract (RVOT) of growing lambs and the function, histological 
changes and potential of growth, and tissue regeneration of PDO were investigated. 
Autologous blood-derived MSCs were labeled with quantum dots and seeded on PDO 
electrospun valved patches. Those were implanted into the RVOT of 6 growing lambs followed 
up until 8 months. Tissue-engineered RVOT were neither stenotic nor aneurismal and 
displayed a growth potential, with less fibrosis, less calcifications and no thrombus compared 
with control polytetrafluoroethylene (PTFE)-pericardial patches. The PDO scaffold was 
completely degraded and replaced by a viable, three-layered, endothelialized tissue and an 
extracellular matrix with elastic fibers similar to that of native tissue. Detection of quantum 
dots at 1 month suggested that at least some of the cells were-derived from the grafted cells. 
The PDO electrospun tissue-engineered valved transannular patch appears to be a promising 
device in restoring a living RVOT and could ultimately lead to applications in the treatment of 
congenital RVOT diseases. The same group further compared electrospun scaffolds of PU, 
poly(3-hydroxybutyrate-co-3- hydroxyvalerate-co-4-hydroxyvalerate (PHBVV) and PDO, using 
two biofunctionalization techniques: adipose-derived stem cells or arginine-glycine-aspartate 
(RGD) peptide in a rat model of partial inferior vena cava replacement [117]. In vitro studies 
using adipose-derived stem cells and in vivo results revealed the superior properties of PDO, 
while the two functionalization methods yielded similar outcomes. 
Moreover, electrospun scaffolds obtained by mixing poly[1,8-octanediol-co-(citric acid)-co-
(sebacic acid)] (POCS) and fibrinogen in various ratios have been utilized for cardiac tissue 
engineering [118]. These composites have shown flexibility and biodegradability. Culture with 
human CMs revealed that the scaffold POCS/fibrinogen with ratio 1:1 is the optimum with 
excellent cell growth and no toxicity and has a potential for cardiac tissue regeneration. 
Another interesting approach is the so-called “cell electrospinning” introduced ten years ago 
by Jayasinghe and co-workers, which demonstrated the ability to directly electrospin living 
cells for the development of living scaffolds [119]. This technique is based on the use of a 
coaxial needle arrangement where a concentrated living biosuspension flows through the 
inner needle and a polymeric medium (poly(dimethyl siloxane)) with high viscosity and low 
electrical conductivity flows through the outer needle. Their research revealed that the high 
  
19 
 
applied voltage did not directly have an adverse effect on the cells as the current in these 
experiments was kept in very low values (nanoamperes). Recently, this group demonstrated 
the ability to directly handle primary neonatal CMs as concentrated cellular suspensions for 
the formation of living cardiac fibers and scaffolds using cell electrospinning [120]. The in vitro 
studies indicated that the cell electrospinning does not alter CMs viability where the function 
of the latter is maintained. 
Table II summarizes the scaffolds characteristics, in terms of synthetic polymers based 
materials, fibers morphology, in vitro/in vivo studies. 
 
Table II. Electrospun scaffolds based on synthetic polymeric materials in cardiac tissue 
engineering. 
Material 
Fibers 
morphology 
Cultured cells In vitro In vivo 
Publication 
year 
Ref. 
PCL random CMs    2004 [74] 
PCL random CMs   
 
2005 [75] 
PCL + collagen I & 
III 
random 
coronary artery smooth 
muscle cells (CASMCs)  
  
 
2005 
[78] 
PLLA, PLGA + 
PLLA, PLGA + 
PEG–PLA 
random rat primary CMs    2005 
[87] 
PLGA–gelatin–
elastin  
random H9c2     2006 
[88] 
PEUU-cosprayed 
SMCs 
random 
vascular SMCs isolated 
from rat aorta 
   2006 
[102] 
PEUU random  
pulmonary 
heart valve 
leaflet 
 2006 
[103] 
PCL/gelatin 
PCL/collagen 
PCL/elastin  
random 
adipose-derived stem 
cells  
  
 
2008 
[79] 
PU  
random & 
aligned 
rat primary ventricular 
CMs  
   2008 
[99] 
PU random ESC-derived CMs     2008 [100] 
collagen-PGA  random CSCs     2010 [89] 
PPDL random H9c2     2010 [115] 
PDO 
rectangular 
mandrel, 
random 
autologous blood-
derived MSCs  
  
 RVOT 
of growing 
lambs 
2010 [116] 
PCL/gelatin  
random & 
aligned  
rabbit CMs   
 
2011 
[80] 
PLLA-co-TMC random CMs    2011 [94] 
PGS/gelatin  
core-shell, 
random 
coculture MSCs and 
CMs 
   2011 
[109] 
Blend(PHBV), P(L-
D,L)LA, PGS 
aligned Wharton’s Jelly MSCs     2011 
[111] 
POC/PLCL  random H9c2    2012 [96] 
PU 
random & 
aligned 
mouse embryonic 
fibroblasts on the 
differentiated 
   2012 
[101] 
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phenotype of murine 
ESC-derived CMs 
PEUU with PCL, 
PEO 
random  
pulmonary 
heart valve 
leaflet 
 2012 
[104] 
PGS/gelatin aligned 
neonatal rat cardiac 
fibroblast cells & CMs 
   2013 
[110] 
PGS-PLLA  
core-shell, 
random 
human ESC-derived CMs    2013 
[112] 
3D spring like PCL random rat CMs    2013 [84] 
PLGA-collagen random 
pluripotent ESCs 
differentiation to CMs 
   2014 
[93] 
PCL-PGA random 
cardiac progenitor cells 
(isolated from newborn 
rat heart)  
   2014 
[95] 
PLA-PEGdma random 
VICs and valvular 
endothelial cells (VECs)  
   2014 
[97] 
PCL-treated with 
plasma 
random 
bone-marrow-derived 
MSCs  
  
 rodent 
model of 
chronic MI 
2014 
[85] 
PCL/BPAEDMA  random rabbit CMs    
 
2014 [81] 
Plasma treated 
PHB, PCL, silk, 
PLLA, PA 
random 
mouse cardiac HL-1 cell 
line, cardiac fibroblasts 
and MSCs from dental 
pulp 
  
 Acellul
ar patches -
rat model of 
MI 
2014 
[114] 
PCU, 
Bionate®/PLGA 
random 
H9c2 on PLGA & 
Bionate,  and neonatal 
rat CMs on Bionate 
   2014 
[106] 
cell 
electrospinning 
core-shell, 
random 
primary neonatal CMs    2014 [120] 
PCL coated with 
gelatin 
random murine iPSCs   
 
2015 
[83] 
PCL  random 
valvular interstitial cells 
(VICs) from porcine 
aortic valve  - fibrosa 
layer 
  
 
2015 
[86] 
PLGA aligned hiPSCs   
 
2015 [92] 
PLCL/PEOz random H9c2   
 
2015 [98] 
PEUU random  
pulmonary  
heart valve 
leaflet 
 2015 [105] 
PU/EC 
random & 
aligned 
H9c2   
 
2015 
[107] 
PGS, PBS-DLA random C2C12 myoblast cells    
 
2015 [113] 
PDO, PU, PHBVV random 
adipose-derived stem 
cells 
  
 rat of 
partial inferior 
vena cava 
replacement 
2015 [117] 
POCS/fibrinogen random human CMs    
 
2015 [118] 
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From the aforementioned, it becomes apparent that there is flexibility in the use of a variety of 
polymeric materials, both natural and synthetic, in any combination which can be electrospun 
and can lead to functional scaffolds for cardiac tissue engineering. Using blended polymers in 
the initial solution prior to electrospinning or utilizing coaxial electrospinning for the formation 
of core/shell nanofibers is an attractive option for balancing the weaknesses of one polymer 
with the strengths of another. There is a huge amount of work focusing on the struggle of 
adjusting the mechanical properties of the scaffolds. It is unsafe at the moment to conclude 
which of the reported scaffolds meets better the criteria of an ideal cardiac scaffold as 
different results obtained by using different type of cardiac cells. Nevertheless, it becomes 
evident that elastomeric materials are preferential in a mechanically dynamic environment, 
such as the cardiovascular tissue. The results obtained by using synthetic scaffolds were 
superior. Last in terms of the structure, when random and aligned fibers were compared for 
the myocardium tissue engineering, the latter had a clear precedence. This is an open field, 
and the research is expected to grow during the coming years in the field of heart cell therapy. 
Nevertheless, in furtherance of achieving a functional scaffold, more consistent studies should 
be carried using the same type of cardiac cells, preferentially human derived stem cells, in 
synergy with cell-seeding conditions using appropriate bioreactors. 
 
4.  Methods for Improving Scaffolds Functionalities 
It is self-evident that the material properties of the electrospun nanofibers play a huge role in 
the interactions between the scaffolds and cardiac cells. In terms of viability, the most 
important properties are those of the surface and not the bulk of the material. As in many 
other applications, a specific material might be suitable for the creation of the scaffold, but its 
surface properties may not be suitable for cardiac cell growth. Instead of using other materials, 
it is quite common to modify the polymer of interest and to induce the desired properties on 
the surface or the bulk. Using several techniques, the microenvironment of the scaffold at the 
interface between the cells and the polymer, where they adhere and interact with the scaffold 
itself, can be improved. In some other cases, a particular modification might be employed to 
improve a desired functionality of the electrospun nanofiber surfaces, which corresponds to 
the desired change of the interaction of the material with the cardiac cells. The classification of 
the modification methods presented herein includes co-electrospinning by combining 
biological elements and  conductive materials, and surface post treatment with wet (chemical) 
and dry (plasma) techniques (figure 5). In many cases, a combination of these methods has 
been reported for the achievement of the optimum scaffold. 
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Figure 5. Classification of the functionalization methods of electrospun scaffolds in cardiac tissue 
engineering. 
 
4.1 Co-electrospinning with additives (pre-treatment) 
4.1.1 Co-electrospinning with biological materials 
One very common method used is the incorporation of biological materials in the initial 
polymeric material, and subsequent electrospinning of the mixture (co-electrospinning). This 
way, a polymer that lacks a specific biological functionality can be improved. Usually, this 
pertains to the survival and the normal behavior of cardiac cells that are cultured in the 
scaffolds. These biomaterials seem to efficiently improve adhesion, viability, and 
biocompatibility of the scaffolds while other properties like differentiation towards a specific 
type of cells appears to be affected in specific cases.  
Yu et al. incorporated short peptides previously covalently conjugated to poly-L-lysine. Two 
adhesive peptides N-acetyl-GRGDSPGYG (RGD) and N-acetyl-GYIGSRGYG (YIGSR) – both 
deriving from laminin – were mixed with PLGA to electrospin, and compared to laminin –
coated PLGA scaffolds [121]. In vitro studies using rat CMs indicated that the cells cultured on 
the YIGSR incorporated and the laminin-coated aligned scaffolds showed physiological-like 
morphology, while the overall superior behavior corresponded to the YIGSR-PLGA. 
Spadaccio et al. proposed the functionalization of PLLA electrospun fibers with granulocyte 
colony-stimulating factor (G-CSF) [122]. G-CSF has shown to have a direct effect on CMs, by 
restraining apoptotic behavior and remodeling in a failing heart as well as by protecting from 
ventricular arrhythmias. This is achieved by the up-regulation of connexin 43 (Cx43). By adding 
G-CSF, the orientation of stem cell differentiation can be controlled, and important local and 
systemic effects can be wielded to adjust the myocardial microenvironment. Also by using G-
CSF, the mechanical properties of the scaffold produced by electrospinning mimics more the 
properties of the natural connective tissue. 
Bhaarathy et al. have incorporated 2 different components in the initial polymer to improve 
different functionalities [123]. Their study uses PLCL, silk fibroin (SF) and Aloe Vera (AV) to 
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create a scaffold via electrospinning so as to use it as an implantable material. The study 
showed that the myocardial microenvironment was influenced positively in terms of cellular 
adhesion, morphology, proliferation and protein expression for neonatal rat CMs. The 
nanofibers of PLCL/SF/AV showed elasticity and mechanical properties similar to those of the 
myocardium, also giving a positive environment in terms of contractility. The presence of Aloe 
Vera also adds up to the functionality of the scaffold and its potential use as a cardiac patch, 
since it induces anti-allergic and anti-inflammatory effects to the electrospun scaffold.  
Simón-Yarza et al. used a polymer blend containing PLGA and six-armed star-shaped 
poly(ethylene oxide-stat-propylene oxide) with isocyanate end groups (NCO-sP(EO-stat-PO) 
with 80% EO content, to encapsulate the cardioactive growth factor Neuregulin-1 (Nrg) [124]. 
The evaluation of the electrospun scaffold with the encapsulated biomaterial was performed 
in a rat model of myocardial ischemia, regarding biocompatibility, adherence, and degradation. 
The study outcomes showed a promising therapeutic strategy for the repair of myocardial 
tissue, since the constructed synthetic scaffold yielded results consistent with constructive 
tissue remodeling. 
 
 
Figure 6. Schematic representation of emulsion electrospinning for producing core–shell nanofibers. 
Reprinted with permission from [125]. 
 
In addition to the above, one of the most sophisticated electrospun scaffolds was proposed by 
Tian et al. which developed PLCL electrospun scaffolds by emulsion electrospinning, a 
technique for the formation of core–shell nanofibers (figure 6) [125]. Aiming to develop a 
sustained release scaffold which could be a promising substrate for cardiovascular tissue 
regeneration, Tian et al. encapsulated VEGF, which is an indispensable bioactive growth factor 
for cardiovascular regeneration, with either dextran or bovine serum albumin (BSA) into the 
core of PLCL nanofibers by emulsion electrospinning. Dextran and BSA acted as the protective 
agents in order to maintain the bio-activity of the encapsulated VEGF in the electrospun PLCL. 
In vitro release study of VEGF using phosphate buffered saline revealed that the PLCL–VEGF–
dextran nanofibers are capable of delivering the growth factor in a more sustained manner. 
The same group used core/shell nanofibrous scaffolds of PGS and fibrinogen where they 
injected VEGF and MSCs in an in vivo porcine model with infarcted myocardium [126]. The in 
vivo studies demonstrated that most of the transplanted MSCs within the scaffolds expressed 
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the cardiac marker proteins and prevented negative ventricular remodeling of the myocardium 
by offering structural support to the left ventricle wall. 
Similarly, introduction of VEGF in electrospun mats using the water-oil emulsion method was 
utilized for synergistically inducing angiogenesis and cardiomyogenesis in an acute myocardial 
infarction model of rats [127]. Epicardial co-implantation of VEGF and CSCs using a PLLA 
electrospun mat enabled the sustained release of VEGF, leading to improved cell retention, 
neovascularization, engraftment rate and enhanced global cardiac function.  
Overall this method gives the advantage of incorporating biological materials in the bulk of the 
nanofiber and thus introducing all the desired biological functionalities. This way the new 
composite material will have better biocompatibility. The absence of the necessary adhesive 
sequences that are essential for cell adhesion and cell viability [128] can be drastically 
improved. Combining the properties of the initial polymer and its suitability for 
electrospinning, a new advanced material is aimed to be created. On the other hand, this 
approach shows similar disadvantages as the use of biological materials does. The initial 
mechanical properties are becoming inadequate with the increase of the addition of the 
biological component [129]. Additionally, there is always the risk of rapid degradation in the 
electrospinning process of the biological materials in a way that the fibers loose the function 
and activity of the incorporated biological materials [130]. Also, the material itself should be 
homogenized to avoid variability of biological properties in the nanofibers. All this tuning 
needed for this approach to be effective also increases the cost.  
This method although seemingly simplistic becomes complex due to the complexity of the 
biological materials by nature, and to their non-compatibility with the method of 
electrospinning. Potentially a biomaterial synthesized with the use of biological elements in a 
way that it can show increased mechanical properties could be a better alternative than this 
approach. 
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4.1.2 Co-electrospinning with conductive materials The ventricle in the human body 
shows a remarkable contractility. The mechanism underlying this ability of 
contraction is driven by the synchronous contraction of CMs. In order for the 
CMs to contract successfully, an electrical signal drives the contraction and is 
supported by the mechanical properties of the human myocardium. Thus, we 
can claim that one of the most important issues for cardiac tissue engineering 
is the improvement in scaffold conductivity (appropriate conduction velocity). 
Controlling conductivity in electrospun scaffolds will help to promote the 
functionalization and maturation of regenerated tissues. The materials that 
are traditionally used for the utilization of the electrospun scaffolds do not 
combine appropriate mechanical and electrical properties. This is the reason 
behind the inability of engineered tissues to keep up with the pace of 
contraction of the native myocardium. As a result, when a scaffold is 
implanted in the heart, it is common that arrhythmias are observed [131]. 
Scaffolds with the desired conductivity could sense the native electrical signals 
successfully and prevent arrhythmias. This way, they could promote CMs 
rhythmic contraction and subsequently direct the differentiation of cardiac 
tissues in vitro, since rhythmic contraction can promote cell alignment and 
electrical coupling of cultured cardiac cells [44]. 
Another strategy used in order to enhance the functionalities of the electrospun scaffold is the 
addition and dispersion of functional agents in the initial solvent of the polymer to create a 
composite so that after electrospinning, the added functionalities will affect the behavior of 
cells. These could be nanoparticles or functional polymers which are added to the initial 
solution and co-electrospun with the initial polymer, similar as in the previous case of adding 
biomaterials. Therefore, to improve conduction velocity of the scaffold to an appropriate value 
as mentioned before, conductive and biocompatible additives can be used for co-
electrospinning.  
Carbon nanotubes in general, have been used as additives in several cases to improve the 
conductivity of polymers, since they show excellent conductive properties and descent 
biocompatibility [132,133]. Based on these studies Crowder et al. proposed the addition of 
multiwall carbon nanotubes (MWCNTs) in PCL [134]. This way the conductivity was up to 35 
mS/cm, depending on the composition. Human MSCs that were cultured on the scaffolds 
created with this composite material containing MWCNTs showed an elongated morphology 
which is similar to that of CMs while there was a strong colocalization between mouse 
antihuman myosin heavy chain (α-MYH) and F-actin cytoskeleton, thereby suggesting  early 
cardiac differentiation. Kharazila et al. also incorporated CNTs in PGS/gelatin electrospun 
nanofibers improving the electrical conductivity along with the mechanical properties of the 
fibers without affecting negatively any biological properties. The resulting scaffolds showed 
enhanced beating properties for the cultured cardiac tissue [135].  
Gold has been used extensively for cell studies due to its biocompatibility and high stability. 
The incorporation of gold nanoparticles (AuNPs) is another conductive substance that is used 
to improve conductivity and mechanical properties. Fleischer et al. added AuNPs to PCL and 
reported that this addition of AuNPs affected the morphology of the cardiac tissues [136]. The 
morphology of the cells was elongated and aligned, which mimics the morphology inside the 
myocardium. Another work proposes the electrospinning of incorporated AuNPs to 
Bis(trimethylsilyl)acetamide (BSA)/Poly(vinyl alcohol) (PVA) mixture [137]. The scaffold created 
was used for culturing MSCs and the differentiation was reported. The cells showed the 
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characteristic morphology of cardiac cells, as well as cardiac protein expression for actinin, 
Troponin-T and Cx43, leading to conclude that AuNP loaded-caffolds provoked the functional 
differentiation of MSCs. The same group used a PCL/Silk Fibroin/Vitamin B12/Aloe Vera/AuNP 
mixture to create scaffolds and direct the differentiation of MSCs into cardiac lineage [138]. 
The MSCs were co-cultured with cardiac cells on the fabricated scaffolds. AuNPs and Vitamin 
B12 provided the functionalities in terms of chemistry and physical properties towards the 
enhancement of the MSCs proliferation and differentiation into cardiogenesis, a fact that was 
measured by the phenotype and the cardiac marker expression in the differentiated MSCs.  
Jung et al. also combined the incorporation of AuNPs as well as peptides with 
polymethylglutarimide (PMGI) to create electrospun scaffolds, which potentiated cardio- 
myocyte differentiation of human ESCs and iPSCs [139].  
 
 
Figure 7. Schematic representation of aligned conductive PANI/PLGA nanofibers fabrication, cell 
seeding, electrical stimulation and the mechanisms of the synchronous cell beatings. Reprinted with 
permission from [140]. 
 
One also common method to improve conductivity is the incorporation of conductive 
biocompatible polymers in the same way as described previously (co-electrospinning). 
Polyaniline (PANi) and polypyrrole (PPy) are the two most used conductive polymers for co-
electrospinning [140–143] [144]. By using this approach, an electrically active scaffold can be 
created, which will coordinate the synchronous beating of cultured CMs in the scaffold. These 
materials (PANi and PPy) are compatible and amenable to the electrospinning technology, 
while their conductivity can be manipulated by the change of the percentage of the conductive 
polymer in the initial mixture. For example Hsiao et al. fabricated nanofibers by co-
electrospinning of PANI with PLGA (figure 7) [140]. The main difficulty here lays in the fact that 
their chemical composition can be affected by this process, which may change their biological 
and mechanical properties.  
In total, this method incorporates materials that can induce specific functionalities to the bulk 
of the material and focuses mostly on the properties side of the material used for 
electrospinning. The mechanical properties can very easily be tuned into the desired ones, as 
well as advanced functionalities like conductivity can be achieved. This approach has the 
advantage of excellent compatibility and suitability of the process itself. The science used to 
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promote the desired functionalities is well established and in most of the cases the materials 
used are of lower cost than the equivalent biological ones described in 4.1.1. For all the above 
the chemical and mechanical properties of the produced nanofibers can be highly reproducible 
[145]. 
On the other hand in most of the cases, a further step is needed since biocompatibility of the 
produced nanofibers is low. Also the fact that most of the polymers are hydrophobic creates 
an additional difficulty in culturing cells on the fibers, especially for the more hydrophobic 
ones. Additionally, toxicity [146][147][148] and biodegradation is a big concern and is 
problematic when nanoparticles are used [130]. Although this method can provide advanced 
functionalities on the electrospun nanofibers that are produced, it lacks essential 
functionalities that have to do with mimicking the ECM. Further additional steps are needed to 
improve cell adhesion on the surface. As stated in 4.1.1, unless there is a biocompatible, non-
toxic and non-degrading material with these specific functionalities, it will be highly unlikely 
that this approach by itself can produce the desired electrospun nanofibers to create a scaffold 
for in vivo application. 
 
4.2 Surface modification of electrospun nanofibers (post-treatment) 
4.2.1 Post treatment by chemical modification 
One of the most important factors on the fabrication of functional materials for biological 
applications is the modification of the surface chemistry. This can be achieved either by 
introducing functional groups on the surface of the material or by modifying the existing 
functional groups [149]. 
Hsiao et al. used hydrochloric acid (HCl) to induce positive charges on the surface of co-
electrospun polyaniline (PANI) and PLGA fibers (fig. 7) [140]. This way they achieved to dope 
the surface of the fibers with positive charges and thus attract the negatively charged adhesive 
proteins fibronectin and laminin improving CM attachment on the scaffolds.  
Shevach et al. [150] proposed the deposition of 2-14 nm AuNPs on the surface of co-
electrospun PCL–gelatin fibers (figure 8). The AuNP coated scaffolds promoted the alignment 
and the elongation of cardiac tissue compared to the non-coated ones. Also, the ratio of CMs 
to fibroblasts was maintained in the culture, promoting an impressive cardiac sarcomeric 
actinin expression. The contractility of the AuNP coated scaffolds was also enhanced compared 
to the non-coated one, exhibiting higher contraction rate and amplitude.  
 
 
Figure 8. Schematic representation of the evaporation of gold NPs onto electrospun PCL–gelatin fiber 
scaffolds and the subsequent cell seeding. Reprinted with permission from [150]. 
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Another approach used for improving specific functionalities of the electrospun scaffolds is 
polymerization on the surface of the fibers. Jin et al. polymerized pyrrole on the surface of 
PLLA scaffold, creating discrete hollow polypyrrole (PPy) fibers with deep (100 μm) 
interconnected pores [151]. This structure allowed the entry of CMs and showed excellent 
results for proliferation and morphology of the cultured cells.  In another study, dopamine was 
also polymerized on the surface of PLCL [152]. Polydopamine allowed gelatin immobilization 
on the surface, without affecting the mechanical properties of the electrospun nanofibers. 
Additionally polydopamine and gelatin synergistically affected CM adhesion and proliferation. 
A post-treatment with a biologically active substance is also a very common method for the 
improvement of the biological properties of the electrospun fibers. The scaffolds are incubated 
in solutions containing the biological substance, which coats the surface of the fibers. 
Fibronectin is the most widely used biological substance for cardiac cells and has been coated 
on chitosan [68], PCL [153] [84], PLA [154] and PU [99]. Collagen type-I was also used on P(L-
D,L)LA [111] and laminin on PLGA [121]. In all cases, the cells show improved attachment, 
proliferation, and viability, while in some cases the desired shape of CMs is achieved. 
NaOH is commonly used to chemically modify the surface of electrospun scaffolds in tissue 
engineering. It has been used both in PLLA and PCL scaffolds to make their surfaces 
superhydrophilic by introducing –OH on the polymer surface. The cultured cells showed 
favourable morphology and adhesion [155,156]. The only study reported so far to use NaOH 
for cardiac tissue engineering, uses it to etch biofunctionalized PLGA, without apparently 
taking advantage of the change in chemistry of the polymer surface [121].  
Summarizing, this method induces chemical and/or biological changes on the surface of the 
electrospun nanofibers to modify and improve the surface properties of the initial material 
used for electrospinning. The main advantage of this approach lies in the fact that the bulk of 
the nanofiber is not affected and thus does not change properties. This way, a material with 
desired mechanical properties can be used for the process of electrospinning (it can also be a 
co-electrospun advanced material like the aforementioned in section 4.1), which subsequently 
is modified (bio)chemically to improve the biocompatibility, cell adhesion and cell viability in a 
uniform and homogeneous fashion. The main disadvantage would be that some of the 
processes may degrade rapidly, while in other cases the chemical modification can decompose 
the material if it affects it at a bigger depth [129]. In addition, although the chemistry of the 
surface can be modulated to mimic the ECM of the myocardium, there is also the 
nanomorphology of the nanofibers that in most of the cases is not following the same 
approach. Chemistry is controlled, but structuring of the surface is either not changed or not 
done in a controlled fashion [157] to induce desired structural changes on the surface of the 
electrospun nanofibers. Although this method is simple, direct, and cost effective, if coupled 
with a more sophisticated method it can significantly increase production cost [158]. 
All in all this approach, if combined with the methods described in section 4.1, can be a very 
promising technique towards which more research should be directed. Research should be 
focusing on understanding the mechanisms responsible for the attachment cells on the 
modified surfaces, i.e. covalent bonding or sorption (e.g. physisorption, chemisorption, 
adsorption), so that the nature of the changes that these biochemical processes induce is fully 
controlled and explained. There is a lot of research on the chemical modification and its 
potential shows that more focus will be put on this technique in the near future.   
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4.2.2 Post treatment by plasma  modification 
Plasma treatment is one of the most extensive methodologies that are used to improve 
specific properties and functionalities of materials. Biological properties can be controlled and 
modified via the intrinsic ability of plasma to modify surface properties of polymers, like 
surface chemistry, ζ-potential, wettability, electrical conductivity and morphology [159–161] 
[162]. 
Guex et al. [85] used a radio-frequency plasma source to modify the surface of PCL fibers. An 
oxygen functional hydrocarbon coating was deposited on the PCL fibers using a mixture of 
ethene (C2H4), carbon dioxide (CO2) and argon (Ar) for 15 min. XPS analysis confirmed the 
formation of an oxygen functional hydrocarbon layer, on the surface of the PCL fibers by 
plasma polymerization. These plasma coated PCL fibers were tested in vivo in a rat model and 
had shown good mechanical integrity (figure 9).  
 
 
Figure 9. Photographs of an implanted MSC patch in a rat heart. (A) Patch placement on the beating 
heart. (B) Patch 4 weeks after implantation where neo-vessels are apparent on its surface. (C) 
Transversal cut of an excised heart, which reveals the strong adherence to left ventricle wall (patch 
contours are represented in dashed lines). Scale bar: 5 mm. Reprinted with permission from [85]. 
 
Bhaarathy et al. use air plasma treatment to improve the wettability of the surface of PLCL, SF 
and AV blend biocomposite nanofibrous scaffolds [123]. Plasma treated samples become more 
hydrophilic, allowing the attachment of cardiac cells as well as the desired proliferation and 
shape. Likewise Castellano et al. utilized N2 plasma for the introduction of polar groups onto 
the surface of PHB, PCL, PLLA, silk, PA electrospun scaffolds prior to cell culture [114]. 
Plasma surface modification as a method for improving the surface properties is quite unique 
as it can induce many different changes on the surface simultaneously or selectively one by 
one. Another advantage is the fact that it can change selectively areas of interest and not the 
whole area of the scaffold comparing to all the other methods, giving this method the option 
to create multifunctional scaffolds using one tool. Plasma in principle creates chemical 
modification by introducing energetic ions on the surface and subsequently changes 
conductivity and surface energy [161]. As in section 4.2.1 it can be used as a different kind of 
chemical modification method for biomolecule immobilization and this way improving cell 
adhesion, proliferation, and viability [163]. It can be used as a deposition tool for a variety of 
coatings, or it can increase the surface of the nanofibers by graphitization [161]. Due to its 
nature, plasma also creates nanostructuring on surfaces either due to etching or due to 
deposition [159][160][162][164][165], so it can also be a tool for the reconstruction of the 
desired micro/nanoenvironment that mimics the cardiac ECM. Finally, an additional advantage 
is the UV irradiation that plasma creates by default and is a benefit on the decontamination of 
surfaces. The disadvantages of this method are mostly due to the fact of the anisotropic nature 
of plasma. Because of this, the parts that are “shaded” on the vertical movement of the ions 
fail to functionalize. Also, the use of vacuum systems increases the complexity and the cost of 
the process comparing to a simple chemical modification and the use of a single chemical.  
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Concluding, plasma surface modification can achieve multiple functionalities using a single 
method, which is a unique advantage comparing to all the aforementioned methods. Although 
this method is not widely used for electrospun nanofibers due to its disadvantages, the recent 
advances in atmospheric pressure plasma systems, combined with the very recent science of 
microplasmas (plasma sources the size of microns), can provide a new tool for achieving the 
desired morphology and functionalities of the electrospun nanofiber scaffold. There is very 
little research done so far in this area, but this method shows great potential. The science of 
plasma surface modification for tissue engineering has been thoroughly investigated in the last 
10 years for polymeric films, and this in combination with recent technologies of plasmas, it 
can provide the desired solutions towards the functionalization of electrospun scaffolds for 
cardiac tissue engineering. 
 
Table III summarizes the scaffolds details in the modification methods described above. The 
references that are included in the tables I and II, but described in the current section as well 
regarding their modification are not included in the table III once more. 
 
Table III. Modification of electrospun scaffolds in cardiac tissue engineering. 
Material 
Fibers 
morphology 
Modification Cultured cells In vitro In vivo 
Publication 
year 
Ref. 
PANi blend random gelatin H9c2    2006 [143] 
PLA random fibronectin neonatal rat CMs    2010 [154] 
poly-L-lysine dendrimers 
(HPLys) + PANi 
random  neonatal rat CMs    2010 
[144] 
PCL random PANi human MSCs    2011 [141] 
PCL + Polypyrrole (PPy) random gelatin rabit CMs    2011 [142] 
PLCL random 
polydopamine + 
gelatin 
neonatal rat CMs    2011 
[152] 
PLLA random G-CSF CMs    2011 [122] 
PLCL random 
VEGF + BSA or 
dextran emulsion 
human bone 
derived MSCs 
   2012 
[125] 
PMGI random peptides + AuNPs 
human ESCs & 
iPSCs 
   2012 
[139] 
fluffy PPy scaffold random 
polymerized 
from fluffy PLLA 
neonatal rat CMs    2012 
[151] 
PCL aligned 
MWCNTs 
+gelatin coating 
human MSCs    2013 
[134] 
PCL random Sputtered AuNPs neonatal rat CMs    2013 [150] 
PLGA aligned PANi +HCl neonatal rat CMs    2013 [140] 
PLGA 
random & 
aligned 
2 adhesive 
peptides RGD, 
YIGSR, laminin-
coating 
primary CMs 
from neonatal 
rats 
  2014 
[121] 
PLCL random 
silk fibroin+ Aloe 
Vera + Air plasma 
CMs from 
neonatal rats 
 
 
2014 
[123] 
PGS:gelatin aligned CNTs neonatal rat CMs    2014 [135] 
PCL coiled fibers AuNPs neonatal rat CMs    2014 [136] 
PVA/BSA random AuNPs human MSCs    2014 [137] 
PGS/fibrinogen random VEGF+MSCs 
human bone 
derived MSCs 
 
 porcine 
model of 
2015 
[126] 
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differentiated 
into cardiac & 
endothelial cells 
myocardial 
infarction 
PLLA random VEGF + CSCs CSCs  
 rat model of 
myocardial 
Infarction 
2015 
[127] 
PCL random fibronectin 
neonatal rat 
cardiac cells 
(CM's + 
fibroblasts) 
 
 
2015 
[153] 
PCL/SF/AV/VitB12/AuNPs   
rabbit CMs + 
human MSCs 
  2015 
[138] 
PLGA/NCO-sP(EO-stat-
PO) 
random + Neuregulin-1   
 rat model of 
myocardial 
ischemia 
2015 
[124] 
 
Conclusions 
An overview of the polymeric electrospun scaffolds used so far for cardiac tissue engineering 
purposes has been reported in this review. Authors’ opinion is that there is not a unique 
material that can be considered as a panacea for cardiac therapy. Most of the scaffolds made 
by synthetic polymers need post treatment in order to obtain sufficient cell attachment. 
Electrospun scaffolds can be modified using several methods; out of them the most commonly 
used are the co-electrospinning of materials that can improve desired functionalities of the 
initial polymer, and the deposition of biologically functional coatings. Both of them are quite 
simple and non-specialist methods, but can prove to be quite complex in some cases in terms 
of chemical stability, since they can induce undesired changes in the composition of the initial 
polymer.  
In addition, although there are several studies showing the effect of changes in the nanoscale 
in other types of cells and tissues, for the case of cardiac cells only a few recent studies 
examine the effect of the nanoscale on the viability, attachment, shape and proliferation of 
cardiac cells (all of them not on 3D scaffolds). This effect of nanoscale induced changes, can 
tune protein expression and direct the behaviour of cardiac cells, as is the case in other types 
of cells. One could comment and predict that useful insights on the mechanisms of the nano-
environment of the myocardium could be given with the aforementioned studies, and this 
could lead to better control on the fabricated scaffolds, this time in the nanoscale.   
Regarding to surface post-treatment, plasma modification shows a lot of potential and there is 
a huge new interest in the use of plasma to attach, modify and direct cells on electrospun 
nanofibers. The unique ability of plasmas to modify the local chemistry and the surface 
characteristics simultaneously gives them an advantage over other surface modification 
methods. Comparing to the case of using solution chemistry to modify the surface of an 
electrospun nanofiber, plasma provides a lot more control in the amount of chemical species 
used as well as a fully controlled environment for the sample in most of the cases. Additionally, 
the ability to deposit materials with plasmas and also etch using the same equipment could be 
used to create nanotextured surfaces by “knitting” selectively specific areas of the surface, 
leading to fully controlled micron or nano scale regions with different functionalities. For these 
reasons plasma was extensively studied the last few years in terms of tissue engineering for 
several types of cells, but still, there are only a few studies for cardiac cells. 
Though the complexity of cardiac tissue is much bigger than many other types of cells, it is very 
clear that there is a lot of room for the employment of the techniques that are used in the 
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modification of scaffolds for the culturing of other type of cells to cardiac cells. Thus, the 
following years there will be a lot of development in this area.  Generally speaking from the 
studies published so far, it is indicated that composite scaffolds, by combining natural and 
synthetic polymers, are more promising candidates. Their principal advantage is that they can 
synergistically combine the beneficial characteristics of each individual component to form a 
material with superior mechanical/elastic and electrical properties together with the essential 
presence of natural ECM protein adhesion ligands to the cells.  
From the above, it is evident that the material of choice is tightly related to the target 
application:  
- Is an implant to transfer cardiac cells to a part of heart required e.g. left ventricle and then 
removed? In this case, a bioresorbable polymer is the best choice. However, the possibility of 
using a natural polymer that has been modified in order to enhance its mechanical properties 
that in the end it will not degrade or at least degrade slightly is an attractive option as this 
material will not cause any toxicity and inflammation and it will be connected smoothly with 
the ECM. At this point, it is worth noting that the crosslinking method is of paramount 
importance in the case of natural electrospun polymers, as it can affect the 3D structure of the 
scaffold. Special attention should be taken in order not to induce cytotoxicity, as it has been 
observed with glutaraldehyde. 
- Is a polymeric material that replaces a part of heart, such as a valve, required? Then a 
biocompatible but not biodegradable, neither bioresorbable material can be considered as the 
ideal choice. 
As an epilogue, from the aforementioned scientific findings, it is observed that the vast 
majority of the studies concern in vitro results, since only a limited number of published 
articles present in vivo results (see tables I, II, III). Despite the variety of accepted biomaterials 
for clinical applications and successful in vitro studies, just only a few studies describe the 
effective implantation of cardiovascular tissue engineered scaffolds into small animals, and 
even less using large animals. In vivo studies should focus more on the usage of large animals 
that simulates better the human heart and more precisely the human heart rate, even though 
the higher cost is a hindrance. 
In either way, it is a fact that the flurry of experimental papers on cardiac scaffolds sharply 
contrasts with their so far scarce clinical applications, primarily limited to the use of collagen 
and fibrin. This is an issue that postulates the concern of the scientists in the field, in order to 
progress in the final target of the implantation of the fabricated electrospun scaffolds in the 
heart. There are different reasons for this discrepancy: the delayed recognition that delivery 
tools are key factors of the successful outcome of any cell-based intervention and the 
subsequent underuse of the scaffolds designed as cell vehicles; the lack of precise 
understanding of how a given cell type responds to the microenvironmental physical and 
chemical cues provided by a given material, which may have prevented to fully benefit from 
effective cell-material interactions. The main regulatory constraints include the availability of 
the selected scaffold material for human use (including its unrestricted supply, the full 
traceability of all its components and a detailed description of their sourcing), the 
documentation of its biocompatibility (assessed by specific tests to probe cytotoxicity, 
mutagenicity, the extent of the inflammatory and immune responses), the characterization of 
its degradation kinetics and biodistribution patterns and the maintenance of the key material 
properties following a clinically-usable mode of sterilization and storage. It is also mandatory 
that the scaffold can be manufactured according to a robust, scalable and reproducible quality-
controlled process. When the scaffold is intended to be used as a vehicle for cells, cell-material 
interactions also need to be characterized.  
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Electrospinning thus appears as an attractive method might help addressing some of these 
obstacles. In particular it allows, by leveraging the various adjustable settings, to fine-tune the 
3D architecture of the scaffold and thus to optimize the patterning of cells (those seeded or 
embedded in the material as well as those from the host) and/or bioactive ligands in a 
controlled and reproducible fashion which should be helpful for translating the material into a 
clinically-targeted "product". Alternatively, in an era where the paracrine effects of the cells 
are considered their primary mechanism of action, leading to think that they might be 
successfully replaced by their secretome, the precise control over the nanofibrillar scaffold 
network could optimize its functionalization by biologics with regard to their retention and 
release kinetics. Electrospinning could also contribute to expanding the indications of cardiac 
scaffolds by allowing the versatile fabrication of cell-material composites usable as epicardial 
patches intended to be deposited onto the epicardium during a surgical procedure. Finally, 
some of the features of the electrospinning technique, primarily scalability, consistency, and 
reproducibility, might facilitate both industrial production and compliance with regulatory 
requirements.   
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